A Cross Sectional Disease/Condition Focused Observational Study on chronic obstructive pulmonary disease (COPD) - PREFER

Study identifier:RO-2455-402-IT

ClinicalTrials.gov identifier:NCT02100332

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Prevalence of Comorbidities of COPD in the Exacerbator Phenotype - A Cross Sectional Disease/Condition Focused Observational Study on COPD

Medical condition

Chronic Obstructive Pulmonary Disease

Phase

-

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

860

Study type

Observational

Age

45 Years - 85 Years

Date

Study Start Date: 01 Nov 2012
Primary Completion Date: 01 Jul 2014
Study Completion Date: 01 Jul 2014

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Sept 2016 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria